كابيكيتابين CAS 154361-50-9 لسرطان الثدي وسرطان اللوركيتال

منطقة الشحن
حول العالم/كل البلدان
CAS
154361-50-9
تحليل
99%
طريقة التسليم
خط FedEx/DHL/خاص
اسم المنتج
كابيكيتابين
الخدمة
خدمة جيدة
التخزين
احتفظ به في مكان بارد وجاف
طريقة الاختبار
HPLC
التسليم
تُقدَم وجبة سريعة من 5 إلى 7 أيام
مدة الصلاحية
سنتان
المظهر
مسحوق أبيض
حزمة النقل
Foil Bag
تخصيص
99%
العلامة التجارية
Xi′an Frazer Biotech Co., Ltd.
الأصل
China
القدرة الإنتاجية
200kg Per Month
السعر المرجعي
$ 23,400.00 - 36,000.00
اتصل بنا

وصف المنتجات

Capecitabine CAS 154361-50-9 for Breast Cancer and Colorectal Cancer
Capecitabine CAS 154361-50-9 for Breast Cancer and Colorectal Cancer
Capecitabine CAS 154361-50-9 for Breast Cancer and Colorectal Cancer

Specification of Analysis

Product Name Capecitabine 
Appearance White powder
Molecular formula C15h22fn3o6
Molecular Weight 359.35
CAS 154361-50-9
Melting Point 110-121°C

What is  Capecitabine ?

Capecitabine is rapidly absorbed by the intestinal mucosa after oral administration, and then converted into an inactive  intermediate 5'-deoxy-5' fluorocytidine in the liver by carboxyl esterase, followed by cytidine removal from liver and  tumor tissues. The action of the aminoase is converted to 5'-deoxy-5' fluorouridine and finally catalyzed by thymidine  phosphorylase to fluorouracil (5-FU) in tumor tissues. Clinical studies have shown that the concentration of 5-FU in tumor tissue after oral administration is significantly  higher than that of blood and muscle. The efficacy of tumors in a variety of animals was significantly higher than 5-FU.

Function

1.Colorectal Cancer (either as neoadjuvant therapy with radiation, adjuvant therapy or for metastatic cases)
2.Breast cancer (Metastatic or as monotherapy/combotherapy, this is licensed as a second-line treatment in Uk)
3.Gastric Cancer (off-label  in the US, this is licensed indication in UK)
4.Oesophageal Cancer (off-label in US)

Application

Anticancer drugs are mainly used for non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

 

 
 
 
 
 
 

 

المركبات الوسيطة الصيدلانية

PNEUTEC.IT, 2023